LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
Código de la empresaLSBPW
Nombre de la empresaLakeShore Biopharma Co Ltd
Fecha de salida a bolsaJul 30, 2021
Fundada en2020
Director ejecutivoMr. Dave Chenn
Número de empleados- -
Tipo de títulosCompany Warrant
Fin del año fiscal- -
Dirección- -
Ciudad- -
Bolsa de valoresNASDAQ Capital Market Consolidated
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Código de la empresaLSBPW
Fecha de salida a bolsaJul 30, 2021
Fundada en2020
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

No datos encontrados